You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PNAS this week: genomic features of certain enterohemorrhagic Escherichia coli strains, gene drive to modify malaria mosquitoes, and more.
The partners aim to identify signatures to predict the severity of disease in those infected and determine how patients will respond to therapies.
A Glasgow University-led team says the livestock-infecting bluetongue virus may have re-emerged through contaminated frozen stocks.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.
Patients who enroll will have their samples tested as part of routine diagnostic care, making it easier for them to take part in clinical trials without additional testing.
In Science this week: computer model uses genomic data to investigate RNA virus outbreaks, and more.
Researchers trained a machine-learning model to predict animal reservoirs or insect vectors for dozens of "orphan" viruses with unknown natural sources.
In PLOS this week: genetic loci tied to chronic back pain, genetic diversity of vampire bat-borne Bartonella bacteria, and more.
In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.
The effort, which relied on Oxford BioDynamics' EpiSwitch platform, resulted in an assay that researchers believe could be developed into a test to guide therapy selection for patients.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.